Source:http://linkedlifedata.com/resource/pubmed/id/10386034
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-9-15
|
pubmed:abstractText |
Beta-lactamase activity was determined using a nitrocefin disc method on 34 Mycobacterium tuberculosis (M. tuberculosis) strains and 13 nontuberculous mycobacteria strains. In the 34 M. tuberculosis strains, 23 strains showed beta-lactamase activity. In 10 Mycobacterium avium complex strains, no beta-lactamase activity was detected. In the Mycobacterium chelonae strains, all three strains examined showed strong beta-lactamase activity. No correlation was found between beta-lactamase activity and resistance to anti-tuberculous chemotherapeutic agents. Four patients who were persistently positive for multi-drug-resistant M. tuberculosis (MDR-TB) on sputum and positive in beta-lactamase activity, were treated with penicillin/beta-lactamase inhibitor combinations. In two cases, the trials were discontinued because of diarrhea; the trials were continued in the remaining two for four months, but the MDR-TB was positive during the course of the therapy. Effectiveness of the therapy with penicillin/beta-lactamase inhibitor combinations against M. tuberculosis was obscure, although many of M. tuberculosis examined showed beta-lactamase activity.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Ampicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Clavulanic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Penicillins,
http://linkedlifedata.com/resource/pubmed/chemical/Sulbactam,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-9776
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
447-52
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10386034-Amoxicillin,
pubmed-meshheading:10386034-Ampicillin,
pubmed-meshheading:10386034-Clavulanic Acid,
pubmed-meshheading:10386034-Drug Resistance, Multiple,
pubmed-meshheading:10386034-Drug Therapy, Combination,
pubmed-meshheading:10386034-Enzyme Inhibitors,
pubmed-meshheading:10386034-Humans,
pubmed-meshheading:10386034-Mycobacterium avium Complex,
pubmed-meshheading:10386034-Mycobacterium chelonae,
pubmed-meshheading:10386034-Mycobacterium tuberculosis,
pubmed-meshheading:10386034-Penicillins,
pubmed-meshheading:10386034-Sulbactam,
pubmed-meshheading:10386034-Tuberculosis, Multidrug-Resistant,
pubmed-meshheading:10386034-beta-Lactamases
|
pubmed:year |
1999
|
pubmed:articleTitle |
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
|
pubmed:affiliation |
Department of Internal Medicine, Kumamoto National South Hospital, Japan.
|
pubmed:publicationType |
Journal Article,
English Abstract
|